Category: china retractions

Serial figure fakers have expression of concern upgraded to a retraction

Another retraction has appeared up for frequent fliers Jun Li, Kailun Zhang and Jiahong Xia at Huazhong Science and Technology University in Wuhan, China.

We’ve covered them twice before, for a variety of retractions, corrections, and expressions of concern.

The retraction, in Clinical and Experimental Immunology, upgrades an expression of concern published earlier this year, and is the team’s fourth.

Here’s the notice for “CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice”: Continue reading Serial figure fakers have expression of concern upgraded to a retraction

“Authors, please call us. Pretty please? OK, we’re going to retract your paper!”

dovelogoThe title of this post isn’t exactly how the one-sided conversation between the editors of Neuropsychiatric Disease and Treatment and a group of researchers went. But it seems likely it was pretty close.

Here’s an expression of concern for “A cross-sectional study on perception of stigma by Chinese schizophrenia patients:” Continue reading “Authors, please call us. Pretty please? OK, we’re going to retract your paper!”

“Lack of experience and understanding” forces duplication retractions of liver cancer paper

dovelogoA group of researchers in China has lost their paper on liver cancer after the first author admitted to duplication, also known, inelegantly, as self-plagiarism.

The paper, “Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells,” appeared in the July 2013 issue of the Journal of Drug Design, Development and Therapy, a Dove Press title.

According to the abstract: Continue reading “Lack of experience and understanding” forces duplication retractions of liver cancer paper

Rice researcher in ethics scrape threatens journal with lawsuit over coming retraction

Guangwen Tang, a rice researcher at Tufts University, landed in hot water in 2012 after her team was accused of feeding Chinese children genetically modified Golden Rice without having obtained informed consent from the parents.

Now, she’s suing both Tufts and the American Journal of Clinical Nutrition, which reportedly is retracting a paper, “ß-carotene in Golden Rice is as good as p-carotene in oil at providing vitamin A to children,” based on the federally funded research, claiming that the retraction would constitute defamation. (That retraction hasn’t happened yet.)

This isn’t the first time we’ve heard the retraction = defamation line. Readers might remember Ariel Fernandez, who threatened to sue us for writing about an expression of concern. Maybe a course on the Streisand Effect should be mandatory for PhD students?
Continue reading Rice researcher in ethics scrape threatens journal with lawsuit over coming retraction

Recursive plagiarism? Researchers may have published a duplicate of a study retracted for plagiarism

acta physica sinicaSometimes plagiarism, like an onion, has layers.

That appears to be the case in a paper brought to our attention by sharp-eyed reader Vladimir Baulin, whose work was copied in a 2006 paper that Journal of Biological Physics retracted for plagiarism.

But you can’t keep a good thief down: the plagiarizing authors just popped up in a new journal with a Chinese-language version of their retracted paper, that looks an awful lot like a knock-off. Here’s a note from Baulin: Continue reading Recursive plagiarism? Researchers may have published a duplicate of a study retracted for plagiarism

Misconduct prompts retraction of prostatectomy paper

jsrcoverA group of urologists in China has lost their 2012 paper in the Journal of Surgical Research because one of the authors was evidently rather naughty.

The article, “Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study,” purported to show that: Continue reading Misconduct prompts retraction of prostatectomy paper

Author steps in to clarify vague tuberculosis retraction

You’ve got to love when an author is willing to detail the specifics of an unhelpful retraction notice.

This May, a paper came out in Journal of Thoracic Diseases about drug-resistant tuberculosis. It was retracted in June, for “some misconduct in the manuscript.”

Here’s the notice:

The article “Application status of MALDI-TOF mass spectrometry in the identification and drug resistance of Mycobacterium tuberculosis” (doi: 10.3978/j.issn.2072-1439.2014.02.19) that appeared on page 512-516 of the May 2014 issue of the Journal of Thoracic Disease needs to be withdrawn due to some misconduct in the manuscript. We are sorry for the inconvenience caused.

Since that’s pretty vague and unhelpful, we reached out to corresponding author Jiayun Liu, who gave us a thorough rundown:

Continue reading Author steps in to clarify vague tuberculosis retraction

If only more retractions could be like this: Authors of cardiac stem cell paper show the way

Researchers at Qingdao University have fully retracted a paper originally published in Molecular Medicine Reports with a clear, detailed outline of what went wrong and how they discovered the error.

Here’s the notice for “Generation of induced pluripotent stem cells using skin fibroblasts from patients with myocardial infarction under feeder-free conditions:”

Continue reading If only more retractions could be like this: Authors of cardiac stem cell paper show the way

Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells

logoThe editors of PLoS ONE have issued an Expression of Concern (which seems likely to become a retraction) for a 2014 paper by a group of researchers in China who claim to have been led astray by a contractor hired to “edit the language” of the report.

The article, “Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein,” came from a group in the Department of Hematology at the First Affiliated Hospital at Xi’an Jiaotong University, and was led by Yuwang Tian, a pathologist at the General Hospital of Beijing Military Area of PLA.

Or at least that’s what the manuscript eventually said. According to the expression of concern, however, that’s not what it said initially: Continue reading Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells

If it smells like pig sh@#, it probably is pig sh@#: A stinky retraction

biores techA group of authors in China has lost their 2011 paper in Bioresource Technology on pig poop because the journal detected a whiff of the familiar in a previously published article by other researchers in the same journal (a major tsk tsk and, well, oops).

The article, “Feasibility of biogas production from anaerobic co-digestion of herbal-extraction residues with swine manure,” came from a team at Nanchang University. Except, well, not really, as we’ll see. According to its abstract:
Continue reading If it smells like pig sh@#, it probably is pig sh@#: A stinky retraction